Mechanistic Elucidation and Therapeutic Improvement of Anti-CTLA-4 Therapies
Anti-CTLA-4 antibodies have successfully elicited durable tumor regression in the clinic; however, long-term benefit is limited to a subset of patients for select cancer indications. The incomplete understanding of their mechanism of action has hindered efforts at improvement, with conflicting hypot...
Main Author: | |
---|---|
Other Authors: | |
Format: | Thesis |
Published: |
Massachusetts Institute of Technology
2023
|
Online Access: | https://hdl.handle.net/1721.1/151592 |